AUDENZ (Seqirus Pty Ltd)
Product name
AUDENZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
212 (255 working days)
Active ingredients
Influenza virus haemagglutinin
Registration type
NCE/ NBE
Indication
AUDENZ is indicated for active immunisation against influenza A in persons from 6 months of age and older in an officially declared pandemic.